Abstract:OBJECTIVE:Neonatal septicemia is a common and severe infection, which often results in death. Early diagnosis and treatment of neonatal septicemia may help decrease neonatal mortality. Recently, many studies sought to explore the possibility of early diagnosis of this disease. The high affinity Fcgamma-receptor I (CD(64)) was purposefully chosen as a potential marker for identifying neonatal septicemia. The present study was designed to evaluate neutrophil CD(64) level for early diagnosis of neonatal septicemia. METHODS:Eighty-nine suspected neonatal septicemia cases were recruited into the study. Five non-specific indices, i.e., C-reactive protein (CRP), micro-erythrocyte sedimentation rate (mESR), white blood cell count, platelet count and the ratio of immature neutrophil count to total neutrophil count were measured for each patient. The patients were divided into septicemia group (n = 39) and non-septisemic infection group (n = 50) according to the diagnostic criteria for neonatal septicemia. Nineteen hospitalized neonates with non-infectious diseases were enrolled as controls (n = 19). The levels of peripheral blood neutrophil CD(64) were measured by using flow cytometry. The positive rate, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of CD(64) were calculated. RESULTS:The levels of peripheral blood neutrophil CD(64) in septicemia patients were (75.6 +/- 8.9)%, which were significantly higher than those of non-septisemic infection group (29.1 +/- 6.2)% and control group (5.1 +/- 1.1)% (P < 0.05), respectively. There were no significant differences in the levels of CD(64) expression between the patients with Gram-negative (79.5 +/- 3.5)% and Gram- positive (76.4 +/- 5.0)% (P > 0.05) bacterial infection. The levels of CD(64) of the cases with septicemia significantly decreased at day 10 of treatment with antibiotics. The detection of CD(64) (cutoff value > 30%) for suspected septicemia showed high sensitivity (97.4%), specificity (84.0%), PPV (82.6%), and NPV (97.6%). The positive rate of CD(64) detection (62.9%) was much higher than that of the blood culture test (19.1%) and that of the five nonspecific indices (29.2%, P < 0.05, respectively). CONCLUSION:The expression of CD(64) increased in neonatal septicemia cases. The measurement of cell surface expression of CD(64) on neutrophils may be helpful to early diagnosis, evaluation of severity of infection and observation of therapeutic effects for neonatal septicemia.

Diagnostic accuracy of neutrophil CD64 expression in neonatal infection: a meta-analysis.

Expression of Peripheral Blood Neutrophil CD64 in Neonatal Septicemia

Meta-analysis of diagnostic accuracy of neutrophil CD64 for neonatal sepsis

[Expression of Neutrophil Adhesion Molecule CD11b As an Early Diagnostic Marker for Neonatal Sepsis].

Predictive significance of neutrophil-to-lymphocyte and platelet-to-lymphocyte for cytomegalovirus infection in infants less than 3 months: A retrospective study

Neutrophil CD64 Expression As a Diagnostic Marker for Sepsis in Adult Patients: a Meta-Analysis

Diagnostic Utility Of Neutrophil Cd64 As A Marker For Early-Onset Sepsis In Preterm Neonates

Neutrophil CD64 Index As a Good Biomarker for Early Diagnosis of Bacterial Infection in Pregnant Women During the Flu Season

Examining the utility of the CD64 index compared with other conventional indices for early diagnosis of neonatal infection

Evaluation of CD64 expression on neutrophils as an early indicator of neonatal sepsis

Evaluation of adhesion molecules CD64, CD11b and CD62L in neutrophils and monocytes of peripheral blood for early diagnosis of neonatal infection

Clinical Study of CD64 Combined with Chemokine in Neonatal Sepsis

Monocyte CD64 Does Not Enhance Neutrophil CD64 As a Diagnostic Marker in Neonatal Sepsis.

Neutrophil CD64 expression as a biomarker in the diagnosis of infectious disease

Diagnostic Role of CD64 on Different Immune Cells in Early Diagnosis of Neonatal Sepsis

Neutrophil CD64 index for diagnosis of infectious disease in the pediatric ICU: a single-center prospective study

Neutrophil CD64 combined with PCT, CRP and WBC improves the sensitivity for the early diagnosis of neonatal sepsis

Significance of neutrophilic CD64 as an early marker for detection of neonatal sepsis and prediction of disease outcome

Is Neutrophil CD11b a Special Marker for the Early Diagnosis of Sepsis in Neonates? A Systematic Review and Meta-Analysis

Neutrophil CD64 index as a superior indicator for diagnosing, monitoring bacterial infection, and evaluating antibiotic therapy: a case control study

Utility of Cytokines to Predict Neonatal Sepsis.